These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30458195)

  • 1. Loss of DUSP2 predicts a poor prognosis in patients with bladder cancer.
    Yin H; He W; Li Y; Xu N; Zhu X; Lin Y; Gou X
    Hum Pathol; 2019 Mar; 85():152-161. PubMed ID: 30458195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Dual-Specificity Phosphatase 2 (DUSP2) in Patients with Serous Ovarian Carcinoma and in SKOV3 and OVCAR3 Cells In Vitro.
    Liu W; Tian X; Ding X; Zhang L
    Med Sci Monit; 2019 Dec; 25():10180-10189. PubMed ID: 31889045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DUSP2 affects bladder cancer prognosis by down-regulating MEK/ERK and P38 MAPK signaling pathways through PTPN7.
    Zou F; Rao T; Chen W; Song T; Li T; Hu W; Li L; Yu W; Cheng F
    Cell Signal; 2023 Dec; 112():110893. PubMed ID: 37739277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of dual-specificity phosphatase-2 promotes angiogenesis and metastasis via up-regulation of interleukin-8 in colon cancer.
    Lin SC; Hsiao KY; Chang N; Hou PC; Tsai SJ
    J Pathol; 2017 Apr; 241(5):638-648. PubMed ID: 28026024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.
    Zhu X; Qiao Y; Liu W; Wang W; Shen H; Lu Y; Hao G; Zheng J; Tian Y
    Tumour Biol; 2016 Apr; 37(4):4569-77. PubMed ID: 26503215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of miR-222 is associated with poor prognosis in bladder cancer.
    Zhang DQ; Zhou CK; Jiang XW; Chen J; Shi BK
    World J Surg Oncol; 2014 Jul; 12():241. PubMed ID: 25078265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
    Tang K; Wang C; Chen Z; Xu H; Ye Z
    Int J Clin Exp Pathol; 2015; 8(5):4999-5007. PubMed ID: 26191193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of S100C is associated with bladder cancer progression and poor survival.
    Memon AA; Sorensen BS; Meldgaard P; Fokdal L; Thykjaer T; Nexo E
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):606-11. PubMed ID: 15701847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of dual-specificity phosphatase-2 by hypoxia increases chemoresistance and malignancy in human cancer cells.
    Lin SC; Chien CW; Lee JC; Yeh YC; Hsu KF; Lai YY; Lin SC; Tsai SJ
    J Clin Invest; 2011 May; 121(5):1905-16. PubMed ID: 21490398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2).
    Qin Y; Chen X; Liu Z; Tian X; Huo Z
    Med Sci Monit; 2018 Jul; 24():4944-4951. PubMed ID: 30011263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inhibited dual-specificity phosphatase-2 expression in endometriotic cells regulates cyclooxygenase-2 expression.
    Wu MH; Lin SC; Hsiao KY; Tsai SJ
    J Pathol; 2011 Nov; 225(3):390-400. PubMed ID: 21984126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
    Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
    Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of microRNA-100 in patients with bladder cancer.
    Cao YH; Zhang HH; Xu HF; Duan YJ; Li Q; Huang B
    Genet Mol Res; 2015 Dec; 14(4):15948-54. PubMed ID: 26662386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
    Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
    Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P3H4 is correlated with clinicopathological features and prognosis in bladder cancer.
    Li W; Ye L; Chen Y; Chen P
    World J Surg Oncol; 2018 Oct; 16(1):206. PubMed ID: 30322400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
    Ning XH; Qi YY; Wang FX; Li SC; Jia ZK; Yang JJ
    Biomed Res Int; 2020; 2020():7272960. PubMed ID: 33150179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual role of TGFBR3 in bladder cancer.
    Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
    Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer.
    Hu H; Chen Y; Cheng S; Li G; Zhang Z
    Wien Klin Wochenschr; 2017 Jun; 129(11-12):391-397. PubMed ID: 27830363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms.
    Haag T; Richter AM; Schneider MB; Jiménez AP; Dammann RH
    BMC Cancer; 2016 Feb; 16():49. PubMed ID: 26833217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and Overall Survival in Patients with Bladder Cancer.
    Wu D; Lin J; Zhu Y; Zhang H; Zhong Y
    Med Sci Monit; 2019 Jul; 25():5289-5298. PubMed ID: 31310599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.